ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - tezepelumab - תמיסה להזרקה - tezepelumab 110 mg/ml - tezepelumab

ישראל - עברית - Ministry of Health

megapharm ltd - flecainide acetate - תמיסה להזרקה - flecainide acetate 10 mg/ml - flecainide - flecainide - serious sustained life threatening ventricular arrhthymias that have not respoded to other drugs.

ישראל - עברית - Ministry of Health

פארמה סוויס ישראל - כלל האוכלוסיה - ג'ל לעצירת דימומים קלים

ישראל - עברית - Ministry of Health

dr.samuelov importing & marketing ltd, israel - primula root dry extract (6-7:1); extracting agent : ethanol 47.4 % (v/v); thyme herb dry extract (6-10:1); extracting agent: ethanol 70.0 % (v/v) - טבליות מצופות פילם - primula root dry extract (6-7:1); extracting agent : ethanol 47.4 % (v/v) 60 mg; thyme herb dry extract (6-10:1); extracting agent: ethanol 70.0 % (v/v) 160 mg - combinations

ישראל - עברית - Ministry of Health

dr.samuelov importing & marketing ltd, israel - fluid extract derived from ivy leaves (1:1); fluid extract derived from thyme herb (1:2-2.5) - נוזל - fluid extract derived from ivy leaves (1:1) 16.8 mg/ml; fluid extract derived from thyme herb (1:2-2.5) 168 mg/ml

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 120 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - belimumab - אבקה להכנת תמיסה מרוכזת לעירוי - belimumab 400 mg - belimumab - belimumab - benlysta is indicated as add-on therapy in adult patients with active, autoantibody-positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g positive anti dsdna and low complement) despite standard therapy.

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - סירופ - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - anifrolumab - תרכיז להכנת תמיסה לאינפוזיה - anifrolumab 150 mg/ml - anifrolumab